USA - NASDAQ:STRM - US86323X2053 - Common Stock
Taking everything into account, STRM scores 1 out of 10 in our fundamental rating. STRM was compared to 35 industry peers in the Health Care Technology industry. STRM may be in some trouble as it scores bad on both profitability and health. STRM is valued expensive and it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -25.3% | ||
ROE | -82% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 48.29% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.18 | ||
Debt/FCF | N/A | ||
Altman-Z | -5.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.27 | ||
Quick Ratio | 0.27 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:STRM (8/11/2025, 8:05:02 PM)
5.3332
-0.01 (-0.13%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.27 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.1 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -25.3% | ||
ROE | -82% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 48.29% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.18 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 17.98% | ||
Cap/Sales | 4.67% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.27 | ||
Quick Ratio | 0.27 | ||
Altman-Z | -5.15 |